Symbols / HNGE Stock $43.99 -1.68% Hinge Health, Inc.
HNGE (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-08 | main | Evercore ISI Group | Outperform → Outperform | $45 |
| 2026-03-11 | main | RBC Capital | Outperform → Outperform | $55 |
| 2026-02-11 | main | Canaccord Genuity | Buy → Buy | $53 |
| 2026-02-11 | main | RBC Capital | Outperform → Outperform | $50 |
| 2026-02-11 | reit | Citizens | Market Outperform → Market Outperform | $65 |
| 2026-02-11 | main | Evercore ISI Group | Outperform → Outperform | $50 |
| 2026-02-11 | main | Barclays | Overweight → Overweight | $52 |
| 2026-02-11 | reit | Needham | Buy → Buy | $59 |
| 2026-01-23 | init | Freedom Capital Markets | — → Buy | $59 |
| 2026-01-09 | main | Piper Sandler | Overweight → Overweight | $60 |
| 2026-01-09 | init | Wells Fargo | — → Overweight | $68 |
| 2026-01-08 | main | Keybanc | Overweight → Overweight | $70 |
| 2026-01-06 | reit | Needham | Buy → Buy | $59 |
| 2026-01-05 | main | Barclays | Overweight → Overweight | $60 |
| 2025-11-05 | main | Canaccord Genuity | Buy → Buy | $65 |
| 2025-11-05 | main | Barclays | Overweight → Overweight | $65 |
| 2025-11-05 | reit | Piper Sandler | Overweight → Overweight | $71 |
| 2025-10-08 | main | Evercore ISI Group | Outperform → Outperform | $65 |
| 2025-09-23 | main | Morgan Stanley | Overweight → Overweight | $67 |
| 2025-09-11 | main | Stifel | Buy → Buy | $66 |
- Drug-free migraine relief program lands 125+ clients before May rollout - Stock Titan Wed, 29 Apr 2026 14
- Here's Why You Should Add Hinge Health Stock to Your Portfolio Now - Yahoo Finance hu, 02 Apr 2026 07
- Universal Beteiligungs und Servicegesellschaft mbH Purchases 149,777 Shares of Hinge Health Inc. $HNGE - MarketBeat Mon, 27 Apr 2026 09
- Citizens reiterates Hinge Health stock rating on digital health moat - Investing.com Fri, 24 Apr 2026 12
- Insider Sale: CEO & Co-Founder of $HNGE Sells 44,297 Shares | HNGE Stock News - Quiver Quantitative ue, 06 Jan 2026 08
- Why Hinge Health Stock Popped on Wednesday - The Motley Fool Wed, 11 Feb 2026 08
- Is Hinge Health Stock Worth Watching Right Now - Kalkine Media Mon, 27 Apr 2026 17
- HANSAINVEST holds 1.48M shares in Hinge Health (HNGE) per 13G filing - Stock Titan Mon, 27 Apr 2026 11
- Assessing Hinge Health (HNGE) Valuation As Shares Show Recent Uptick But Weak Broader Momentum - Yahoo Finance Fri, 16 Jan 2026 08
- Hinge Health exec chairman sells $1.5m in HNGE stock By Investing.com - Investing.com South Africa Wed, 22 Apr 2026 22
- Insider Selling: Hinge Health (NYSE:HNGE) Chairman Sells 33,333 Shares of Stock - MarketBeat Wed, 22 Apr 2026 21
- Hinge Health (HNGE) director takes RSU shares instead of cash - Stock Titan ue, 07 Apr 2026 07
- Gabriel Mecklenburg’s Share Sale And Conversion Reshape Hinge Health Valuation Story - Yahoo Finance Sat, 14 Mar 2026 07
- Hinge Health Stock Rises After Analysts Back the May IPO's Shares - MSN Sat, 25 Apr 2026 16
- Hinge Health’s AI Moat Might Be Its Patient Movement Data - MarketBeat Mon, 23 Feb 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Revenue |
|
587.86
+50.58%
|
390.40
+33.37%
|
292.73
|
| Operating Revenue |
|
587.86
+50.58%
|
390.40
+33.37%
|
292.73
|
| Cost Of Revenue |
|
119.64
+32.19%
|
90.50
-8.17%
|
98.55
|
| Reconciled Cost Of Revenue |
|
119.64
+32.19%
|
90.50
-8.17%
|
98.55
|
| Gross Profit |
|
468.22
+56.13%
|
299.90
+54.45%
|
194.18
|
| Operating Expense |
|
1,014.59
+205.77%
|
331.81
+2.19%
|
324.69
|
| Research And Development |
|
368.14
+265.07%
|
100.84
-8.38%
|
110.06
|
| Selling General And Administration |
|
646.46
+179.88%
|
230.97
+7.61%
|
214.63
|
| Selling And Marketing Expense |
|
316.95
+89.73%
|
167.06
+13.17%
|
147.62
|
| General And Administrative Expense |
|
329.50
+415.54%
|
63.91
-4.63%
|
67.02
|
| Other Gand A |
|
329.50
+415.54%
|
63.91
-4.63%
|
67.02
|
| Total Expenses |
|
1,134.23
+168.58%
|
422.31
-0.22%
|
423.24
|
| Operating Income |
|
-546.37
-1612.23%
|
-31.91
+75.55%
|
-130.51
|
| Total Operating Income As Reported |
|
-546.37
-1612.23%
|
-31.91
+75.55%
|
-130.51
|
| EBITDA |
|
-541.24
-1984.89%
|
-25.96
+79.21%
|
-124.89
|
| Normalized EBITDA |
|
-541.24
-1984.89%
|
-25.96
+79.21%
|
-124.89
|
| Reconciled Depreciation |
|
5.13
-13.73%
|
5.95
+5.74%
|
5.63
|
| EBIT |
|
-546.37
-1612.23%
|
-31.91
+75.55%
|
-130.51
|
| Net Income |
|
-528.26
-4326.89%
|
-11.93
+88.97%
|
-108.14
|
| Pretax Income |
|
-527.26
-4584.28%
|
-11.26
+89.63%
|
-108.55
|
| Other Income Expense |
|
19.11
-7.49%
|
20.65
-5.98%
|
21.97
|
| Other Non Operating Income Expenses |
|
19.11
-7.49%
|
20.65
-5.98%
|
21.97
|
| Tax Provision |
|
1.00
+47.42%
|
0.68
+267.16%
|
-0.41
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+5150.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-528.26
-4326.89%
|
-11.93
+88.97%
|
-108.14
|
| Net Income From Continuing Operation Net Minority Interest |
|
-528.26
-4326.89%
|
-11.93
+88.97%
|
-108.14
|
| Net Income From Continuing And Discontinued Operation |
|
-528.26
-4326.89%
|
-11.93
+88.97%
|
-108.14
|
| Net Income Continuous Operations |
|
-528.26
-4326.89%
|
-11.93
+88.97%
|
-108.14
|
| Normalized Income |
|
-528.26
-4326.89%
|
-11.93
+88.97%
|
-108.14
|
| Net Income Common Stockholders |
|
-424.09
-3453.90%
|
-11.93
+88.97%
|
-108.14
|
| Otherunder Preferred Stock Dividend |
|
-104.17
|
0.00
|
0.00
|
| Diluted EPS |
|
—
|
-0.15
+90.31%
|
-1.58
|
| Basic EPS |
|
—
|
-0.15
+90.31%
|
-1.58
|
| Basic Average Shares |
|
—
|
78.02
+13.83%
|
68.54
|
| Diluted Average Shares |
|
—
|
78.02
-15.11%
|
91.90
|
| Diluted NI Availto Com Stockholders |
|
-424.09
-3453.90%
|
-11.93
+88.97%
|
-108.14
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Total Assets |
|
744.76
+10.62%
|
673.26
+8.15%
|
622.53
|
| Current Assets |
|
533.90
-8.49%
|
583.45
+10.11%
|
529.88
|
| Cash Cash Equivalents And Short Term Investments |
|
363.86
-22.01%
|
466.57
+10.21%
|
423.36
|
| Cash And Cash Equivalents |
|
208.00
-30.85%
|
300.79
+28.02%
|
234.95
|
| Cash Equivalents |
|
167.57
-36.44%
|
263.66
+29.94%
|
202.90
|
| Cash Financial |
|
40.43
+8.89%
|
37.13
+15.83%
|
32.05
|
| Other Short Term Investments |
|
155.87
-5.98%
|
165.79
-12.00%
|
188.40
|
| Receivables |
|
66.06
+55.46%
|
42.49
-8.74%
|
46.56
|
| Accounts Receivable |
|
51.04
+35.53%
|
37.66
+26.57%
|
29.75
|
| Gross Accounts Receivable |
|
—
|
48.97
-2.07%
|
50.00
|
| Allowance For Doubtful Accounts Receivable |
|
—
|
-6.47
-88.14%
|
-3.44
|
| Receivables Adjustments Allowances |
|
-6.09
+5.84%
|
-6.47
-88.14%
|
-3.44
|
| Other Receivables |
|
21.12
+86.75%
|
11.31
-44.16%
|
20.25
|
| Inventory |
|
15.64
+43.81%
|
10.87
-18.21%
|
13.29
|
| Raw Materials |
|
6.56
+35.71%
|
4.83
+167.81%
|
1.80
|
| Work In Process |
|
0.12
-93.93%
|
1.91
-44.14%
|
3.42
|
| Finished Goods |
|
8.96
+117.05%
|
4.13
-48.83%
|
8.07
|
| Prepaid Assets |
|
30.93
+29.35%
|
23.91
+66.57%
|
14.36
|
| Current Deferred Assets |
|
50.94
+56.03%
|
32.65
+16.83%
|
27.95
|
| Other Current Assets |
|
6.47
-6.80%
|
6.95
+59.06%
|
4.37
|
| Total Non Current Assets |
|
210.86
+134.77%
|
89.81
-3.06%
|
92.65
|
| Net PPE |
|
17.35
+2.14%
|
16.99
-24.43%
|
22.48
|
| Gross PPE |
|
37.13
+10.67%
|
33.55
-2.04%
|
34.25
|
| Accumulated Depreciation |
|
-19.78
-19.42%
|
-16.56
-40.71%
|
-11.77
|
| Properties |
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
30.07
+26.65%
|
23.74
+14.18%
|
20.79
|
| Other Properties |
|
6.86
-28.58%
|
9.61
-27.53%
|
13.26
|
| Leases |
|
0.20
+0.00%
|
0.20
+0.00%
|
0.20
|
| Goodwill And Other Intangible Assets |
|
66.61
+5.04%
|
63.41
-0.59%
|
63.79
|
| Goodwill |
|
64.10
+4.04%
|
61.61
+0.00%
|
61.61
|
| Other Intangible Assets |
|
2.51
+39.01%
|
1.81
-17.30%
|
2.19
|
| Investments And Advances |
|
113.17
|
0.00
|
—
|
| Other Non Current Assets |
|
13.73
+45.84%
|
9.41
+47.59%
|
6.38
|
| Total Liabilities Net Minority Interest |
|
366.23
+42.75%
|
256.56
+31.40%
|
195.25
|
| Current Liabilities |
|
362.41
+45.37%
|
249.30
+35.37%
|
184.16
|
| Payables And Accrued Expenses |
|
45.87
+93.63%
|
23.69
-27.50%
|
32.68
|
| Payables |
|
6.17
+190.94%
|
2.12
-74.14%
|
8.20
|
| Current Accrued Expenses |
|
39.70
+84.07%
|
21.57
-11.88%
|
24.48
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
11.46
+175.26%
|
4.16
-34.62%
|
6.37
|
| Total Tax Payable |
|
6.17
+190.94%
|
2.12
-74.14%
|
8.20
|
| Current Debt And Capital Lease Obligation |
|
4.22
+10.72%
|
3.81
-17.75%
|
4.64
|
| Current Capital Lease Obligation |
|
4.22
+10.72%
|
3.81
-17.75%
|
4.64
|
| Current Deferred Liabilities |
|
300.86
+38.24%
|
217.63
+54.93%
|
140.47
|
| Current Deferred Revenue |
|
300.86
+38.24%
|
217.63
+54.93%
|
140.47
|
| Total Non Current Liabilities Net Minority Interest |
|
3.82
-47.42%
|
7.26
-34.58%
|
11.10
|
| Long Term Debt And Capital Lease Obligation |
|
3.82
-47.42%
|
7.26
-34.58%
|
11.10
|
| Long Term Capital Lease Obligation |
|
3.82
-47.42%
|
7.26
-34.58%
|
11.10
|
| Stockholders Equity |
|
378.54
-9.16%
|
416.70
-2.48%
|
427.28
|
| Common Stock Equity |
|
178.66
+141.11%
|
-434.57
-2.49%
|
-423.99
|
| Capital Stock |
|
199.87
-76.52%
|
851.27
+0.00%
|
851.27
|
| Common Stock |
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
199.87
-76.52%
|
851.27
+0.00%
|
851.27
|
| Share Issued |
|
79.17
+1.48%
|
78.02
+0.00%
|
78.02
|
| Ordinary Shares Number |
|
79.17
+1.48%
|
78.02
+0.00%
|
78.02
|
| Additional Paid In Capital |
|
1,229.68
+1295.82%
|
88.10
+1.56%
|
86.75
|
| Retained Earnings |
|
-1,051.00
-101.06%
|
-522.74
-2.34%
|
-510.80
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.02
-129.41%
|
0.07
+13.33%
|
0.06
|
| Other Equity Adjustments |
|
-0.02
-129.41%
|
0.07
+13.33%
|
0.06
|
| Total Equity Gross Minority Interest |
|
378.54
-9.16%
|
416.70
-2.48%
|
427.28
|
| Total Capitalization |
|
378.54
-9.16%
|
416.70
-2.48%
|
427.28
|
| Working Capital |
|
171.50
-48.68%
|
334.15
-3.35%
|
345.73
|
| Invested Capital |
|
178.66
+141.11%
|
-434.57
-2.49%
|
-423.99
|
| Total Debt |
|
8.04
-27.39%
|
11.07
-29.62%
|
15.73
|
| Capital Lease Obligations |
|
8.04
-27.39%
|
11.07
-29.62%
|
15.73
|
| Net Tangible Assets |
|
311.93
-11.71%
|
353.29
-2.81%
|
363.49
|
| Tangible Book Value |
|
112.05
+122.50%
|
-497.98
-2.09%
|
-487.79
|
| Available For Sale Securities |
|
113.17
|
—
|
—
|
| Investmentin Financial Assets |
|
113.17
|
0.00
|
—
|
| Preferred Stock Equity |
|
199.87
-76.52%
|
851.27
+0.00%
|
851.27
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
171.44
+249.87%
|
49.00
+176.67%
|
-63.91
|
| Cash Flow From Continuing Operating Activities |
|
171.44
+249.87%
|
49.00
+176.67%
|
-63.91
|
| Net Income From Continuing Operations |
|
-528.26
-4326.89%
|
-11.93
+88.97%
|
-108.14
|
| Depreciation Amortization Depletion |
|
5.13
-13.73%
|
5.95
+5.74%
|
5.63
|
| Depreciation |
|
—
|
5.60
+5.66%
|
5.30
|
| Amortization Cash Flow |
|
—
|
0.40
+0.00%
|
0.40
|
| Depreciation And Amortization |
|
5.13
-13.73%
|
5.95
+5.74%
|
5.63
|
| Amortization Of Intangibles |
|
—
|
0.40
+0.00%
|
0.40
|
| Other Non Cash Items |
|
50.10
+49.24%
|
33.57
+41.88%
|
23.66
|
| Stock Based Compensation |
|
643.01
+86910.69%
|
0.74
-55.08%
|
1.65
|
| Provisionand Write Offof Assets |
|
3.06
-43.42%
|
5.41
+11.39%
|
4.86
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
1.81
-82.35%
|
10.26
|
| Deferred Tax |
|
0.05
+109.06%
|
-0.58
-23.68%
|
-0.47
|
| Deferred Income Tax |
|
0.05
+109.06%
|
-0.58
-23.68%
|
-0.47
|
| Change In Working Capital |
|
-2.01
-114.92%
|
13.50
+43.49%
|
9.41
|
| Change In Receivables |
|
-26.63
-1887.09%
|
-1.34
+94.21%
|
-23.13
|
| Changes In Account Receivables |
|
-26.63
-1887.09%
|
-1.34
+94.21%
|
-23.13
|
| Change In Inventory |
|
-4.76
-883.39%
|
0.61
-94.25%
|
10.56
|
| Change In Prepaid Assets |
|
-15.78
-72.31%
|
-9.15
-262.01%
|
5.65
|
| Change In Payables And Accrued Expense |
|
29.41
+367.95%
|
-10.97
-194.96%
|
11.56
|
| Change In Other Working Capital |
|
19.64
-49.17%
|
38.65
+371.52%
|
8.20
|
| Change In Other Current Assets |
|
-0.18
-148.01%
|
0.38
-44.31%
|
0.68
|
| Change In Other Current Liabilities |
|
-3.72
+20.18%
|
-4.66
-13.33%
|
-4.11
|
| Investing Cash Flow |
|
-113.76
-721.25%
|
18.31
+1119.99%
|
1.50
|
| Cash Flow From Continuing Investing Activities |
|
-113.76
-721.25%
|
18.31
+1119.99%
|
1.50
|
| Net PPE Purchase And Sale |
|
-0.71
+31.86%
|
-1.04
+47.42%
|
-1.98
|
| Purchase Of PPE |
|
-0.71
+31.86%
|
-1.04
+47.42%
|
-1.98
|
| Capital Expenditure |
|
-6.06
-60.72%
|
-3.77
+18.24%
|
-4.62
|
| Capital Expenditure Reported |
|
-5.36
-95.90%
|
-2.73
-3.60%
|
-2.64
|
| Net Investment Purchase And Sale |
|
-103.70
-569.54%
|
22.09
+261.10%
|
6.12
|
| Purchase Of Investment |
|
-472.29
-45.52%
|
-324.54
+28.41%
|
-453.33
|
| Sale Of Investment |
|
368.59
+6.34%
|
346.63
-24.56%
|
459.45
|
| Net Business Purchase And Sale |
|
-4.00
|
0.00
|
0.00
|
| Purchase Of Business |
|
-4.00
|
0.00
|
0.00
|
| Financing Cash Flow |
|
-150.47
-6733.24%
|
-2.20
+26.60%
|
-3.00
|
| Cash Flow From Continuing Financing Activities |
|
-150.47
-6733.24%
|
-2.20
+26.60%
|
-3.00
|
| Net Issuance Payments Of Debt |
|
4.93
|
0.00
|
0.00
|
| Issuance Of Debt |
|
4.93
|
0.00
|
0.00
|
| Long Term Debt Issuance |
|
4.93
|
0.00
|
0.00
|
| Net Long Term Debt Issuance |
|
4.93
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
190.65
|
0.00
|
0.00
|
| Common Stock Payments |
|
-65.03
|
0.00
|
0.00
|
| Repurchase Of Capital Stock |
|
-65.03
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
9.53
+1462.13%
|
0.61
+23.98%
|
0.49
|
| Net Other Financing Charges |
|
-355.58
-12545.02%
|
-2.81
+19.47%
|
-3.49
|
| Changes In Cash |
|
-92.79
-242.51%
|
65.11
+199.55%
|
-65.41
|
| Beginning Cash Position |
|
302.59
+27.42%
|
237.47
-21.60%
|
302.88
|
| End Cash Position |
|
209.80
-30.67%
|
302.59
+27.42%
|
237.47
|
| Free Cash Flow |
|
165.38
+265.64%
|
45.23
+166.00%
|
-68.52
|
| Amortization Of Securities |
|
0.36
-32.77%
|
0.54
+104.99%
|
-10.76
|
| Common Stock Issuance |
|
255.68
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
255.68
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-22 View
- 42026-04-07 View
- 42026-04-02 View
- 42026-04-01 View
- 42026-04-01 View
- 42026-03-24 View
- 42026-03-24 View
- 42026-03-18 View
- 8-K2026-03-17 View
- 42026-03-10 View
- 42026-03-03 View
- 42026-03-03 View
- 10-K2026-03-03 View
- 42026-02-24 View
- 42026-02-24 View
- 42026-02-19 View
- 42026-02-18 View
- 42026-02-17 View
- 42026-02-13 View
- 8-K2026-02-10 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|